The Interaction Between Mitophagy Dysregulation and the Diabetic Bladder Microenvironment.

Area of Science:

• Urology
• Mitochondrial Biology
• Diabetic Complications

Background:

• Diabetic bladder dysfunction (DBD) is a common complication of diabetes.
• Its pathogenesis involves hyperglycemia, oxidative stress, and mitochondrial dysfunction.
• The role of mitophagy in DBD and its interaction with the bladder microenvironment are not fully understood.

Purpose of the Study:

• To elucidate a novel, self-reinforcing feedback loop in DBD progression.
• To explore the role of mitophagy impairment in DBD.
• To review potential therapeutic strategies targeting this feedback loop.

Main Methods:

• Literature review of mitophagy pathways (PINK1/Parkin, FUNDC1) and their dysfunction in hyperglycemia.
• Analysis of mitochondrial dysfunction consequences: mtROS production, DAMPs release, NLRP3 inflammasome activation.
• Review of emerging therapeutic interventions for DBD.

Main Results:

• Hyperglycemia impairs mitophagy, leading to damaged mitochondria accumulation.
• Mitochondrial dysfunction exacerbates bladder microenvironment damage via mtROS, DAMPs, and NLRP3 inflammasome activation.
• This aggravated microenvironment further inhibits mitophagy, creating a detrimental cycle.

Conclusions:

• A self-reinforcing loop involving mitophagy impairment and microenvironmental dysregulation drives DBD progression.
• Combined therapeutic strategies restoring mitophagy and modulating the microenvironment are promising.
• Interventions like urolithin A, MCC950, PINK1 mRNA delivery, and Parkin gene editing warrant further investigation.